amivantamab
janssen,genmab
['lcsm,(-blcsm)', 'sclc', 'nsclc', 'chrysalis,(-chrysalis2),(-chrysalis-2),(-chrysalis 2)']
amivantamab - a new option fr mnsclc w/ met exon 14 skipping mutations? new data from chrysalis study show ami has promising efficacy &amp; safety profile for both 1l &amp; 2l options, even in pts who have received prior met tkis. #asco22 #lcsm 
LUNGevity Foundation is dedicated to funding lung cancer research and providing support to ALL people affected by lung cancer.